George A. Scangos
2012 - Biogen
In 2012, George A. Scangos earned a total compensation of $13.5M as Chief Executive Officer at Biogen, a 19% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $38,787 |
|---|---|
| Non-Equity Incentive Plan | $3,785,600 |
| Salary | $1,294,231 |
| Stock Awards | $7,955,654 |
| Other | $377,530 |
| Total | $13,451,802 |
Scangos received $8M in stock awards, accounting for 59% of the total pay in 2012.
Scangos also received $38.8K of change in pension value and nonqualified deferred compensation earnings, $3.8M in non-equity incentive plan, $1.3M in salary and $377.5K in other compensation.
Rankings
In 2012, George A. Scangos' compensation ranked 225th out of 11,487 executives tracked by ExecPay. In other words, Scangos earned more than 98.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 225 out of 11,487 | 98th |
Division Manufacturing | 91 out of 4,253 | 98th |
Major group Chemicals And Allied Products | 20 out of 1,203 | 98th |
Industry group Drugs | 11 out of 925 | 99th |
Industry Biological Products, Except Diagnostic Substances | 3 out of 165 | 98th |
Source: SEC filing on April 30, 2015.
Scangos' colleagues
We found four more compensation records of executives who worked with George A. Scangos at Biogen in 2012.